A(2A) adenosine receptor ligands and proinflammatory cytokines induce PC 12 cell death through apoptosis.

[1]  K. Jacobson,et al.  Adenosine-induced cell death: evidence for receptor-mediated signalling , 1999, Apoptosis.

[2]  K. Klotz,et al.  Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells. , 2002, The Journal of investigative dermatology.

[3]  Neal Castagnoli,et al.  8-(3-Chlorostyryl)caffeine May Attenuate MPTP Neurotoxicity through Dual Actions of Monoamine Oxidase Inhibition and A2A Receptor Antagonism* , 2002, The Journal of Biological Chemistry.

[4]  D. Tuscano,et al.  Up-regulation of A(2A) adenosine receptors by proinflammatory cytokines in rat PC12 cells. , 2002, Biochemical pharmacology.

[5]  Y. Yoo,et al.  Role of p38 MAPK in the regulation of apoptosis signaling induced by TNF-alpha in differentiated PC12 cells. , 2002, Journal of biochemistry and molecular biology.

[6]  T. Stone,et al.  Enhanced neuronal damage by co‐administration of quinolinic acid and free radicals, and protection by adenosine A2A receptor antagonists , 2002, British journal of pharmacology.

[7]  M. Falchi,et al.  Blockade of Striatal Adenosine A2A Receptor Reduces, through a Presynaptic Mechanism, Quinolinic Acid-Induced Excitotoxicity: Possible Relevance to Neuroprotective Interventions in Neurodegenerative Diseases of the Striatum , 2002, The Journal of Neuroscience.

[8]  J. Losy,et al.  Early TNF‐α levels correlate with ischaemic stroke severity , 2001 .

[9]  B. Cronstein,et al.  Inflammatory Cytokines Regulate Function and Expression of Adenosine A2A Receptors in Human Monocytic THP-1 Cells1 , 2001, The Journal of Immunology.

[10]  R. Cunha,et al.  Adenosine as a neuromodulator and as a homeostatic regulator in the nervous system: different roles, different sources and different receptors , 2001, Neurochemistry International.

[11]  E. Ongini,et al.  Adenosine receptors in neurological disorders , 2000 .

[12]  E. Deitch,et al.  Adenosine inhibits IL-12 and TNF-a production via adenosine A 2 a receptor-dependent and independent mechanisms , 2000 .

[13]  K. Jeng,et al.  Induction of cytokine genes and IL-1α by chemical hypoxia in PC12 cells , 2000 .

[14]  M. Sitkovsky,et al.  Study of A2A adenosine receptor gene deficient mice reveals that adenosine analogue CGS 21680 possesses no A2A receptor‐unrelated lymphotoxicity , 2000, British journal of pharmacology.

[15]  F. Pedata,et al.  Striatal A2A adenosine receptor antagonism differentially modifies striatal glutamate outflow in vivo in young and aged rats , 2000, Neuroreport.

[16]  M. Sitkovsky,et al.  A2A receptor dependent and A2A receptor independent effects of extracellular adenosine on murine thymocytes in conditions of adenosine deaminase deficiency , 2000 .

[17]  K. Jacobson,et al.  Induction of apoptosis in rat cardiocytes by A3 adenosine receptor activation and its suppression by isoproterenol. , 2000, Experimental cell research.

[18]  J. Bockaert,et al.  “Inflammatory” Cytokines , 2000, Journal of neurochemistry.

[19]  G. Chrousos,et al.  Ligand-Activation of the Adenosine A2a Receptors Inhibits IL-12 Production by Human Monocytes , 2000, The Journal of Immunology.

[20]  R. Dantzer,et al.  Cytokine signals propagate through the brain , 2000, Molecular Psychiatry.

[21]  F. Cattabeni,et al.  Brain Adenosine Receptors as Targets for Therapeutic Intervention in Neurodegenerative Diseases , 1999, Annals of the New York Academy of Sciences.

[22]  M. Moskowitz,et al.  A2A Adenosine Receptor Deficiency Attenuates Brain Injury Induced by Transient Focal Ischemia in Mice , 1999, The Journal of Neuroscience.

[23]  P. Popoli,et al.  The intrastratial injection of an adenosine A2 receptor antagonist prevents frontal cortex EEG abnormalities in a rat model of Huntington's disease , 1999, Brain Research.

[24]  F. Pedata,et al.  Striatal A2A adenosine receptors differentially regulate spontaneous and K+-evoked glutamate release in vivo in young and aged rats. , 1999, Neuroreport.

[25]  N. Rothwell.  Cytokines ‐ killers in the brain? , 1999 .

[26]  B. Fredholm,et al.  Signaling via A2A adenosine receptor in four PC12 cell clones , 1999, Naunyn-Schmiedeberg's Archives of Pharmacology.

[27]  E. Ongini,et al.  Blockade of adenosine A2A receptors by SCH 58261 results in neuroprotective effects in cerebral ischaemia in rats , 1998, Neuroreport.

[28]  T. Stone,et al.  Protection against hippocampal kainate excitotoxicity by intracerebral administration of an adenosine A2A receptor antagonist , 1998, Brain Research.

[29]  M. Weller,et al.  Induction of Nitric Oxide Synthase and Nitric Oxide‐Mediated Apoptosis in Neuronal PC12 Cells After Stimulation with Tumor Necrosis FActor‐α/Lipopolysaccharide , 1998 .

[30]  B. Cacciari,et al.  Binding affinity of adenosine receptor agonists and antagonists at human cloned A3 adenosine receptors. , 1998, Life sciences.

[31]  C. Franceschi,et al.  Apoptosis by 2-chloro-2′-deoxy-adenosine and 2-chloro-adenosine in human peripheral blood mononuclear cells , 1998, Neurochemistry International.

[32]  T. Stone,et al.  Protection against kainate-induced excitotoxicity by adenosine A2A receptor agonists and antagonists , 1998, Neuroscience.

[33]  D. Millhorn,et al.  Hypoxia regulates the cAMP- and Ca2+/calmodulin signaling systems in PC12 cells. , 1998, Biochemical and biophysical research communications.

[34]  B. Fredholm,et al.  Comparative pharmacology of human adenosine receptor subtypes – characterization of stably transfected receptors in CHO cells , 1997, Naunyn-Schmiedeberg's Archives of Pharmacology.

[35]  E. Ongini,et al.  Adenosine A2A Receptors and Neuroprotection , 1997, Annals of the New York Academy of Sciences.

[36]  Sergi Ferré,et al.  Adenosine–dopamine receptor–receptor interactions as an integrative mechanism in the basal ganglia , 1997, Trends in Neurosciences.

[37]  Markus Schwaninger,et al.  Stimulation of Interleukin‐6 Secretion and Gene Transcription in Primary Astrocytes by Adenosine , 1997, Journal of neurochemistry.

[38]  B. Fredholm,et al.  Neonatal cerebral hypoxia-ischemia: The effect of adenosine receptor antagonists , 1997, Neuropharmacology.

[39]  Y. Chern,et al.  Protein Kinase C Inhibits Adenylyl Cyclase Type VI Activity during Desensitization of the A2a-Adenosine Receptor-mediated cAMP Response* , 1997, The Journal of Biological Chemistry.

[40]  E. Ongini,et al.  The non-xanthine heterocyclic compound SCH 58261 is a new potent and selective A2a adenosine receptor antagonist. , 1996, The Journal of pharmacology and experimental therapeutics.

[41]  P. Popoli,et al.  Adenosine A2A receptor stimulation enhances striatal extracellular glutamate levels in rats. , 1995, European journal of pharmacology.

[42]  G Burnstock,et al.  Nomenclature and Classification of Purinoceptors* , 2005 .

[43]  J. Phillis,et al.  CGS 15943, an adenosine A2 receptor antagonist, reduces cerebral ischemic injury in the Mongolian gerbil. , 1994, Life sciences.

[44]  Y. Chern,et al.  Multiple mechanisms for desensitization of A2a adenosine receptor-mediated cAMP elevation in rat pheochromocytoma PC12 cells. , 1993, Molecular pharmacology.